RICares - News

News

Active Issues

August 24, 20170 Comments


RICARES hopes to have a page in the future with all active issues at a local level and a national level that need to be acted on. We are working towards that. In the meantime check our advocacy page for local agencies working on issues that matter to us.

Faces & Voices of Recovery track all national issues that need our attention. Please keep checking back for updates!

An interfaith memorial service for the 1,250 Rhode Islanders who have died of opioid overdose in the last five years was held Thursday at the First Baptist Church in America in Providence.

An interfaith memorial service for the 1,250 Rhode Islanders who have died of opioid overdose in the last five years was held Thursday at the First Baptist Church in America in Providence. The service was a collaboration of clergy, the St. Matthias Ministry of the Roman Catholic Diocese of Providence and a group known as FIRE, which stands for Faith Infused Recovery Efforts. Besides music and prayer, speakers including personal family stories of the affliction of addiction.

Link to Pictures

Convergence RI

A jarring comment at the close of the June 14 Governor’s Overdose Prevention and Intervention Task Force meeting challenged the way that strategies are being implemented, and whether they benefit the people seeking treatment and recovery.

Governer Gina Raimondo

PHOTO BY RICHARD ASINOF Gov. Gina Raimondo talks at the opening of the new Lifespan Recovery Center on June 19, as Dr. Timothy Babineau, president and CEO of Lifespan, listens attentively.

Read more

Nurse holding patient's hand

There is good news in the campaign to reduce opioid deaths in Rhode Island. Newly released data show the Ocean State is at the top in New England and second best in the nation in reducing the number of opioid prescriptions filled within the past three years. Rhode Island’s numbers fell by 24.8 percent, second only to West Virginia’s 27.6 percent decline. Massachusetts, Maine and New Hampshire all brought their numbers down by better than 20 percent, while Vermont and Connecticut achieved slightly smaller decreases. Nationally, the average decrease was 14.6 percent, but for first time, every state in the union showed a decline.

Read more

Monica and guest

PROVIDENCE – Monica Smith, the new executive director at RICARES, the Rhode Island Communities for Addiction Recovery Efforts, newly arrived from Oregon, admits that she is still learning how best to navigate her way around the policy labyrinths of Rhode Island – and how to properly pronounce the names of towns and cities.

In turn, what she brings to the conversation is a fresh perspective on the dynamics of the recovery movement, one that places an emphasis on building relationships.

Read more

Convergence RI

An alleged intoxicated man transported to Rhode Island Hospital by rescue personnel for detox was reportedly released two hours after being seen, only to die early the next morning – the same day that new standards for emergency departments for treatment of substance use disorders were announced.
By Richard Asinof Posted 3/20/17

Why is this story important?
The story of an alleged intoxicated man transported by rescue personnel to the emergency room at Rhode Island Hospital for detox and reportedly released two hours later, who then died early the next morning, without evidence of foul play, raises questions about how alcoholism fits within the new standards for treatment of substance use disorders by emergency departments.

Read more

Sen Claire McCaskill (D, Missouri) has launched a Senate investigation into whether 5 drug companies marketed their opioid painkillers in a manner that may have contributed to the nation’s opioid epidemic.

In letters to the companies, which include Mylan, Depomed, INSYS Therapeutics, Purdue Pharma, and Johnson & Johnson’s Janssen division, McCaskill demanded internal documents relating to the firms’ marketing tactics, studies the companies conducted that might have alerted them to the risk of addiction and lethal overdose, behind-the-scenes efforts to block increased regulation, and sales quotas that may have led drug representatives to use kickbacks to encourage physicians to prescribe the drugs.

Read more